Media coverage
1
Media coverage
Title Castle Biosciences Presents New Data Demonstrating the Impact of DecisionDx -SCC Test Results on the Management of Medicare-Eligible Patients with Cutaneous Squamous Cell Carcinoma and One or More Risk Factors Media name/outlet Impact Financial News Country/Territory United Kingdom Date 25/10/22 URL metabase.moreover.com/noarticleurl?type=psh&lni=66PH-KTJ1-JDG9-Y47V-00000-00 Persons Matthew Goldberg